Urging The Governor To Reharmonize The Federal And State Regulation Of Cannabis In Hawaii By Obtaining A Controlled Substance Exception For Registered Medical Cannabis Patients And Registration Waivers For State-licensed Medical Cannabis Dispensaries From The Drug Enforcement Administration.
Summary
H.R. 160 is a House Resolution urging the Governor of Hawaii to take steps to align Hawaii’s medical cannabis program with federal drug enforcement rules. The resolution asks the Governor to seek a controlled substance exception for registered medical cannabis patients and registration waivers for state-licensed medical cannabis dispensaries from the U.S. Drug Enforcement Administration (DEA). It also asks the Governor to pursue an exception under federal regulations for Hawaii’s medical cannabis program and to report progress to the Legislature on a quarterly basis.
The resolution explains that Hawaii’s medical cannabis system, created by Act 228 in 2000, has long operated in tension with federal cannabis law. It cites potential harms to patients and dispensaries from that mismatch, including employment consequences, child custody issues, housing eligibility problems, and complications with firearms, insurance, and disability applications. The measure also references a 2025 federal executive order directing expedited rescheduling of marijuana to Schedule III, presenting that as a reason for prompt state action to protect Hawaii’s program and preserve state authority over intrastate medical cannabis use.
Impact
Because this is a resolution rather than a bill, H.R. 160 does not directly amend Hawaii statutes or create new legal rights or obligations. Instead, it directs the Governor to seek federal administrative accommodations from the DEA that would better protect state-licensed medical cannabis patients and dispensaries under Hawaii’s existing medical cannabis framework. Its practical effect would be to encourage executive action and federal coordination, potentially reducing conflicts between state law and federal enforcement for intrastate medical cannabis activity.
Sentiment
The overall sentiment reflected in the resolution is strongly supportive of Hawaii’s medical cannabis program and concerned about the burdens created by federal-state conflict. The measure frames reharmonization as necessary to protect patients, dispensaries, and the State’s regulatory authority. No opposing testimony or recorded votes are provided in the materials, so the available context suggests a one-sided, pro-cannabis administrative reform posture rather than a contested floor debate.
Contention
The main point of contention is the continuing mismatch between Hawaii’s medical cannabis laws and federal controlled substances law, especially the practical consequences for patients and dispensaries. The resolution highlights concerns about discrimination, federal benefit eligibility, and business compliance burdens, while also implying dissatisfaction that the Department of Health did not act on a prior legislative request in HCR 132. Another potential issue is the scope of the Governor’s authority to obtain DEA exceptions or waivers, since the resolution asks for federal relief that may depend on federal agency discretion rather than state action alone.
Same As
Urging The Governor To Reharmonize The Federal And State Regulation Of Cannabis In Hawaii By Obtaining A Controlled Substance Exception For Registered Medical Cannabis Patients And Registration Waivers For State-licensed Medical Cannabis Dispensaries From The Drug Enforcement Administration.
Requesting The United States Congress To Remove Cannabis From The Federal Controlled Substances Act, Provide Support To States That Are In The Process Of Clearing Cannabis Offenses From Defendants' Records, And Facilitate The Full Spectrum Of Banking Services For Cannabis-related Businesses.
Requesting The United States Congress To Remove Cannabis From The Federal Controlled Substances Act, Provide Support To States That Are In The Process Of Clearing Cannabis Offenses From Defendants' Records, And Facilitate The Full Spectrum Of Banking Services For Cannabis-related Businesses.